OrbiMed Israel Partners II, L.P.

Track

Insider profile

OrbiMed Israel Partners II, L.P.'s trades of ADICET Bio, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
65.66
Quantity 90,401
Value US$1,877,285
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-08 2026-04-08
PrS Proposed sale
90,401
65.66
US$1,877,285 		90,401 65.66 US$1,877,285
2023-10-02 2023-10-02
PrS Proposed sale
84,672
50.00
US$184,690 		84,672 50.00 US$184,690
2023-08-30 2023-08-30
PrS Proposed sale
18,725
223.45
US$328,036 		18,725 223.45 US$328,036
2023-08-21 2023-08-21
PrS Proposed sale
631,048
0.62
US$389,357 		631,048 0.62 US$389,357
2023-08-15 2023-08-15
PrS Proposed sale
489,970
0.75
US$367,478 		489,970 0.75 US$367,478
2023-07-31 2023-07-31
PrS Proposed sale
180,300
3.02
US$544,506 		180,300 3.02 US$544,506
2023-07-25 2023-07-25
PrS Proposed sale
4,700
2.35
US$11,045 		4,700 2.35 US$11,045
2023-07-13 2023-07-13
PrS Proposed sale
52,800
2.55
US$134,640 		52,800 2.55 US$134,640
2023-04-10 2023-04-10
PrS Proposed sale
9,064
1.90
US$17,222 		9,064 1.90 US$17,222
2023-04-05 2023-04-05
PrS Proposed sale
43,810
2.24
US$97,915 		43,810 2.24 US$97,915